Research across Cardiac arrhythmias
Related studies from across the Cardiac arrhythmias family.
9 trials tracked for supraventricular tachycardia: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 26 citations.
Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Cryoablation using the Freezor Xtra Catheter demonstrated high chronic effectiveness for the treatment of AVNRT via an endocardial approach over a 6-month period (368 vs. 29; p<0.0001). This efficacy remained consistent in subjects who achieved acute procedural success (368 vs. 10; p<0.0001). The procedure also demonstrated high chronic safety rates during the same timeframe (393 vs. 4; p<0.0001).
Dual Chamber ICDs were evaluated for management of supraventricular arrhythmias. In a study of 100 subjects, only one patient received an inappropriate shock (p=1.0), while zero patients experienced atrial tachyarrhythmia episodes lasting over 5 minutes. However, there was a statistically significant difference in the number of appropriate shocks delivered by the ICD (31 vs. 1; p=0.050).
AI synthesis of 0 cited trials, updated Jun 22, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
Related studies from across the Cardiac arrhythmias family.
